Outcome of Board Meeting

| Updated on February 17, 2016 Published on February 17, 2016

Hester Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 17, 2016, inter alia, has approved the following business:

1. Allotment and Issue of 65 (Sixty Five) Equity shares of the Company to Shareholders of Innoves Animal Health Private Limited pursuant to Scheme of arrangement in the nature of Amalgamation of DiavetraLifesciences Private Limited, Gujarat Agrofarm Limited and Hester Biosciences (Mauritius) Limited with Hester Biosciences Limited and De-merger and Transfer of Trading undertaking of Innoves Animal Health Private Limited into Hester Biosciences Ltd., approved by Honble High Court of Gujarat by order dated December 08, 2015.

2. Approval for the Listing of Shares with the Stock Exchanges where shares of Company listed (BSE and NSE) and to carry out all necessary procedure with the relevant authorities in reference to the said Listing.

Source : BSE - >www.bseindia.com

Published on February 17, 2016
This article is closed for comments.
Please Email the Editor